Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07226596

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Led by William Stoops · Updated on 2026-01-23

300

Participants Needed

1

Research Sites

259 weeks

Total Duration

On this page

Sponsors

W

William Stoops

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.

CONDITIONS

Official Title

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be age 18 years or older
  • Self-report methamphetamine use in the week prior to screening
  • Provide a methamphetamine-positive urine sample at screening
  • Meet DSM-5 criteria for moderate-severe Methamphetamine Use Disorder
  • Be seeking treatment for methamphetamine use
  • Be able and willing to commit to the 12-week intervention and 12-week follow-up
  • Individuals stably maintained on buprenorphine or methadone for Opioid Use Disorder are eligible
Not Eligible

You will not qualify if you...

  • Current or past medical or psychiatric illness that would interfere with participation, such as physical dependence on drugs other than buprenorphine requiring detoxification, unstable angina, uncontrolled cardiac arrhythmia, aortic stenosis, compromised immune function, severe substance use disorder other than MUD or treated OUD
  • Poor venous access preventing blood draws

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Psychopharmacology of Addiction Laboratory

Lexington, Kentucky, United States, 40507

Actively Recruiting

Loading map...

Research Team

W

William W Stoops, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Non-Abstinence Outcomes in Methamphetamine Use Disorder | DecenTrialz